SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix (NFLX) is trending after its latest earnings report, revealing strong ad-tier growth and expanding margins, yet the stock saw a notable decline following cautious forward guidance and the cessation of share buybacks. The community is sharply divided, with many seeing this as a prime long-term buying opportunity, while others anticipate further downside, citing the potential Warner Bros. Discovery acquisition's impact on debt and shareholder value. This pivotal moment highlights a tug-of-war between Netflix's core business strength and strategic M&A concerns.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as escalating geopolitical tensions, including President Trump's tariff threats against European nations over Greenland, and growing concerns about US dollar stability drive investors to seek safe havens. The community is actively discussing gold's role as a premier hard asset amidst broad market uncertainty, anticipating further appreciation as capital potentially rotates from equities and traditional bonds.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid significant market uncertainty, driven by recent geopolitical rhetoric concerning Greenland and potential tariffs. While some investors anticipate a quick V-shaped rebound, others are bracing for further downside, with rising gold prices reflecting broader market anxiety. The community is actively debating whether these developments are temporary "noise" or signal a more substantial correction, especially considering underlying bond market concerns.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to multiple analyst upgrades and recent news of a significant U.S. SHIELD defense contract for chip supply, which the community views as a major catalyst. Investors are actively discussing the upcoming earnings, robust demand for server CPUs driven by AI, and the stock's notable resilience amidst broader market volatility, with many anticipating a move past key resistance levels.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group ($DJT) is trending as conversations focus on President Trump's highly anticipated address at the World Economic Forum in Davos, following an unexpected return of Air Force One due to a mechanical issue. His rhetoric on imposing tariffs against European allies, especially regarding Greenland, is dominating community discussions, sparking concerns about global economic stability and the strength of international alliances. While many supporters view his assertive stance as decisive, critics are expressing apprehension over potential diplomatic fallout and its broader market impact.

America's Oil Reserve for the Digital Age

U.S Oil

USOR Crypto is trending amidst extreme volatility, with community members fiercely debating its legitimacy as a Solana meme coin following a rapid price surge. While some anticipate significant further gains leading up to a key February 1st date, others are cautioning against a potential "rug pull" scenario, with many also discussing its inconsistent availability on various exchanges.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending amidst significant market uncertainty driven by former President Trump's recent geopolitical rhetoric concerning Greenland and tariffs, coupled with anticipation of his upcoming Davos speech. This has spurred intense community debate, with some advocating to "buy the dip" while others voice concerns over a potential market downturn, especially as gold prices reach new all-time highs.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending amidst escalating geopolitical trade tensions and recent service outages, which have contributed to a broader tech sell-off and driven its daily RSI to historically oversold levels. The community is sharply divided between those advocating to "buy the dip" ahead of anticipated strong earnings and others who question its long-term growth trajectory under current market pressures.

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation is trending due to its recent listing on Kraken and increased accessibility via the Base network, alongside new partnerships including a Web3 National Lottery integration in the Philippines. The community is keenly focused on Constellation's strategic shift towards enterprise and government use cases, like its long-standing DoD contracts and recent MiCAR compliance, highlighting its Layer 0 Hypergraph architecture for secure data solutions in the AI era.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending due to reports of a potential acquisition by Zydus Lifesciences, sparking community speculation about a bidding war for the undervalued biotech. This is amplified by recent strong preliminary financial results, accelerated IBSRELA revenue guidance to $1 billion by 2029, and a pivotal patent extension to 2041 for both its key therapies. These developments firmly position Ardelyx as a compelling long-duration asset and an attractive target in the current biotech market landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Silo Pharma's stock buzz increased on Wednesday after the company reported crucial development steps for SPC-15, their main product which serves as an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD).&nbsp;Silo entered into a partnership with Frontage Laboratories to perform a 7-day significant animal safety and toxicology study as requested by the FDA.&nbsp;Shares of the company closed at $0.84 on Wednesday, down 23.3% for the day, and declined further by 4.9% to $0.80 in after-hours trading.Silo is moving forward with an IND-enabling Good Laboratory Practice (GLP)-compliant toxicology and toxicokinetic study focused on SPC-15.Completing the toxicology studies with favorable outcomes will enable the submission of an IND application in 2025.&nbsp;Silo intends to start a first-in-human Phase 1 clinical trial for SPC-15 after receiving approval.&nbsp;The pharma company has obtained an exclusive worldwide license from Columbia University to develop SPC-15 further and enable its manufacturing and commercial distribution.Additionally, Silo also partnered with Veloxity Labs to provide bioanalysis services for its current GLP toxicology and toxicokinetics research.&nbsp;The company confirmed its plan to start the FDA IND process for SPC-15 in 2025, with the goal of advancing to clinical trials once approval is obtained.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 3,300% surge in 24-hour message volume.One user mentioned that buying shares under a dollar has been consistently profitable for them over the past five years, though they plan to exit within three to six months, adding that catching pre-market price spikes requires early mornings.&nbsp;<stembedurl>https://stocktwits.com/Helson/message/614607172</stembedurl>Another user noted they took a 9% gain on the stock and planned to exit soon.<stembedurl>https://stocktwits.com/Bdport/message/614597364</stembedurl>The stock has declined 12% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment

The company announced FDA-requested toxicology studies for its PTSD treatment SPC-15, fueling optimism for a 2025 IND submission and Phase 1 trial.

Equity

After a Patent Win, Analysts Think This Penny Stock Can Gain 465% in 2025

Amid the dynamic biopharma landscape, this penny stock is turning heads with a game-changing patent win, and analysts are buzzing with bullish projections for its potential.

Silo Pharma (SILO) isn't your typical market mover. But on Tuesday, this small-cap biopharma stock defied expectations, skyrocketing over 123% to become the undisputed champion of U.S. gainers. The secret weapon? An exclusive global license agreement for a promising Alzheimer's drug.Wednesday's pre-market trading painted a different picture as the stock fell by as much as 13%, suggesting some investors are taking profits after the wild ride. However, at around 11 am ET, shares had rebounded, gaining over 2%.<figure class="image"><img style="aspect-ratio:1322/756;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SILO_stock_move_Jul_17_c1ed653683.png" alt="SILO stock move Jul 17" width="1322" height="756"><figcaption>SILO stock move Jul 17</figcaption></figure>But hold on, the story doesn't end there. SILO is still capturing retail investor attention like never before. Stocktwits data reveals a surge in interest: the stock has the most new watchers in the past 24 hours, and follower counts have skyrocketed by a whopping 453% over the past week.The excitement stems from a licensing deal for SPC-14, an Alzheimer's drug currently in preclinical development. Silo Pharma plans to leverage the FDA's streamlined pathway, potentially speeding up clinical trials and reducing costs.&nbsp;With the global Alzheimer's treatment market expected to reach a staggering $30.8 billion by 2033, the potential is undeniable.Retail investors on Stocktwits are buzzing, bullish about the deal's potential to supercharge SILO's value. This comes on the heels of a similar licensing agreement for their lead drug candidate targeting stress and PTSD.&nbsp;With shares already up 57% year-to-date and hitting 11-month highs, the latest development could still trigger a retail frenzy for SILO over the longer-term, despite the pre-market dip.Representative <a href="https://pixabay.com/illustrations/neurons-brain-cells-brain-structure-7420662/">image</a> by Gerd Altmann from Pixabay

Why This Small-Cap Biopharma Is Getting The Most Retail Attention On Stocktwits Today

Silo Pharma’s shares more than doubled yesterday, driven by a promising new Alzheimer’s drug agreement.

Silo Pharma’s shares more than doubled yesterday as retail investors flock to the stock, driven by a promising new Alzheimer’s drug agreement.

This account has been verified as an official SILO representative.

Verified Account

Silo Pharma

Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.

SILO Pharma Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

SILO
SILO Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest SILO News

SILOSILO Pharma Inc